MiNK Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
MiNK Therapeutics, Inc.‘s stocks are currently a part of 9 hedge funds’ portfolios, which represents 1.55% of the total amount of its stocks outstanding. This makes up a total of 522.09K shares of MiNK Therapeutics, Inc.. Compared to the previous quarter, the number fell by -19.68% or -127.90K shares fewer. As for the holding position changes, 22.22% (2) of current hedge fund investors increased the number of shares held, 22.22% (2) of current holders sold a part of the shares held, and 33.33% (3) closed the holdings completely. 1 hedge funds are new holders of MiNK Therapeutics, Inc. stock in Q1 2023, it is 11.11% of total holders.
Hedge funds holding MiNK Therapeutics (Q4 2021 – Q1 2023)
Q4 2021 | 21 |
---|---|
Q1 2022 | 19 |
Q2 2022 | 7 |
Q3 2022 | 9 |
Q4 2022 | 17 |
Q1 2023 | 9 |
Hedge funds changes in MiNK Therapeutics positions (Q4 2021 – Q1 2023)
Q4 2021 | 21 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q1 2022 | 6 | 6 | 5 | 8 | -6 |
Q2 2022 | 2 | 0 | 3 | 13 | -11 |
Q3 2022 | 6 | 1 | 0 | 4 | -2 |
Q4 2022 | 8 | 3 | 2 | 0 | 4 |
Q1 2023 | 1 | 2 | 2 | 3 | 1 |
Top 50 hedge fund holders of MiNK Therapeutics, Inc. (NASDAQ:INKT)
Hedge fund | Value | Shares owned | Portfolio share |
---|---|---|---|
ARTAL GROUP S.A. | 611K | 289.58K | 0.026% |
FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. | 172K | 81.5K | 0.000% |
VANGUARD GROUP INC | 104K | 49.10K | 0.000% |
GEODE CAPITAL MANAGEMENT, LLC | 48K | 23.17K | 0.000% |
STATE STREET CORP | 23K | 11.10K | 0.000% |
HIGHTOWER ADVISORS, LLC | 22K | 10.4K | 0.000% |
BLACKROCK INC. Larry Fink | 21K | 10.00K | 0.000% |
ROYAL BANK OF CANADA | 1K | 468 | 0.000% |
UBS GROUP AG | 1K | 258 | 0.000% |
FMR LLC | 0 | 0 | 0.000% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0.000% |
MORGAN STANLEY | 0 | 0 | 0.000% |
TOWER RESEARCH CAPITAL LLC (TRC) | 0 | 0 | 0.000% |